Prospectus Supplement                           Filed Pursuant to Rule 424(b)(3)
(to Prospectus dated April 22, 2005)            Registration No. 333-123862



                 AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY

       $250,000,000 of 5.25% Contingent Convertible Senior Notes due 2024

   $10,000,000 of Series B 5.25% Contingent Convertible Senior Notes due 2024

                                       and

          Shares of Common Stock Issuable Upon Conversion of the Notes


         This prospectus supplement supplements the prospectus dated April 22,
2005, as supplemented by the prospectus supplements dated May 2, 2005, May 11,
2005, May 25, 2005, June 8, 2005, July 1, 2005, July 22, 2005, August 23, 2005,
September 13, 2005, October 4, 2005, November 9, 2005, December 2, 2005 and
December 27, 2005, relating to the resale by certain of our securityholders of
up to $250,000,000 of our 5.25% Contingent Convertible Senior Notes due 2024,
$10,000,000 of our Series B 5.25% Contingent Convertible Senior Notes due 2024
and the shares of our common stock issuable upon conversion of the notes. You
should read this prospectus supplement in conjunction with the prospectus. This
prospectus supplement is qualified by reference to the prospectus, except to the
extent that the information in this prospectus supplement supersedes the
information contained in the prospectus.

         The information appearing under the heading "Selling Securityholders"
in the prospectus is hereby amended by the addition or substitution, as
applicable, of the following:




                                                Aggregate         Percentage of     Number of Shares
                                                Principal      Aggregate Principal   of Common Stock
                                             Amount of Notes     Amount of Notes       That May Be     Percentage of Common
Name                                         That May Be Sold      Outstanding           Sold(1)       Stock Outstanding(2)
-------------------------------------------- ----------------  -------------------  ----------------   --------------------
                                                                               
CBARB, a segregated account of Geode
   Capital Master Fund Ltd. (3) ............       2,500,000           *                172,771                *

---------------

* Represents less than 1%.

(1)  Assumes conversion of all of the holder's notes at a conversion rate of
     69.1085 shares of common stock per $1,000 principal amount at maturity of
     the notes. This conversion rate is subject to adjustment, however, as
     described under "Description of the Notes -- Conversion Rights." As a
     result, the number of shares of common stock issuable upon conversion of
     the notes may increase or decrease in the future.

(2)  Calculated based on Rule 13d-3(d)(i) of the Securities Exchange Act of
     1934, as amended, using 38,375,157 shares of common stock outstanding as of
     February 28, 2005. In calculating this amount for each holder, we treated
     as outstanding the number of shares of common stock issuable upon
     conversion of all of that holder's notes, but we did not assume conversion
     of any other holder's notes.

(3)  An open-ended exempted mutual fund company registered as a segregated
     accounts company under the laws of Bermuda.

   Investing in the notes and our common stock issuable upon their conversion
   involves risks. See "Risk Factors" beginning on page 7 of the prospectus.

-------------------------------------------------------------------------------
          Neither the Securities and Exchange Commission nor any state
           securities commission has approved or disapproved of these
         securities or passed upon the adequacy of this prospectus. Any
                       representation to the contrary is a
                                criminal offense.
-------------------------------------------------------------------------------

           The date of this prospectus supplement is February 3, 2006.